Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
CellVoyant logo — We see the future in cells

CellVoyant

We see the future in cells

Founded 2021 United Kingdom Bristol, United Kingdom 15 employees Total: $7.60M AI, Biotechnology

General Information

Company Name CellVoyant
Founded Year 2021
Location United Kingdom Bristol, United Kingdom
Founders / Decision Makers
Team member Team member
Employees 15
Industries AI, Biotechnology
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Service Fee, Usage Based
Social

BounceWatch is an independent company data service, not affiliated with CellVoyant. To contact CellVoyant, visit cellvoyant.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CellVoyant compare?

A PDF of CellVoyant and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CellVoyant soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CellVoyant

CellVoyant, founded in 2021 and headquartered in the United Kingdom, operates at the forefront of AI and Biotechnology, living up to its slogan, “We see the future in cells.” The company, born from research at the University of Bristol's Carazo Salas lab, leverages AI-first live cell imaging technology to innovate in the field of stem cell-based therapies for chronic diseases.

By integrating cell biology with advanced computer vision, engineering, and machine learning, CellVoyant aims to transform scientific research into scalable industrial solutions. The firm's efforts seek to redefine cell and tissue manufacturing processes, establishing themselves as pioneers in this transformative sector.

On 17 January 2024, the company secured a substantial £7.60M Seed Round investment. The funding round featured participation from esteemed investors such as Air Street Capital, Octopus Ventures, Horizons Ventures, and Verve Ventures, signaling a robust vote of confidence in their innovative approach and potential market impact.

Business keywords: AI-first biotechnology, Stem cell therapy, Live cell imaging, Cell manufacturing, Machine learning, Cell biology, Computer vision, Venture capital, Biotech startup, Research and development, Deep learning, Medical innovation, Science industrialization

Services & Products

FateView™ - AI-powered cell state prediction
FateDrive™ - AI-driven process optimisation

Target Customers

Biotech Companies Pharmaceutical Researchers Cell Therapy Developers Stem Cell Scientists

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC £7.60M 4
Air Street Capital Octopus Ventures Horizons Ventures
Air Street Capital, Octopus Ventures +2
01 Jan 2024
Spinout Undisclosed 1
University of Bristol Enterprise Fund
University of Bristol Enterprise Fund
01 Aug 2021

CellVoyant Alternatives & Competitors

View All Alternatives
CellVoyant vs
Profluent
Profluent United States

Grounded in nature, authored by AI

Venture round
69 employees
AI, Biotechnology
CellVoyant vs
CellVoyant Technologies
CellVoyant Technologies United Kingdom

AI-driven stem cell therapies for chronic diseases. Innovating with precision to manufacture cells a...

Seed
11-50 employees
AI, Biotechnology
CellVoyant vs
Synthego
Synthego United States

Your Partner in CRISPR & Molecular Diagnostics

172 employees
AI, Automation
View all alternatives

FAQ About CellVoyant

We see the future in cells
CellVoyant was founded in 2021.
CellVoyant is headquartered in Bristol, United Kingdom.
CellVoyant operates in AI and Biotechnology. Its work centres on AI-first biotechnology, Stem cell therapy, Live cell imaging and Cell manufacturing. Its customers include Biotech Companies, Pharmaceutical Researchers and Cell Therapy Developers.
CellVoyant has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Service Fee and Usage Based.
CellVoyant has approximately 15 employees.
CellVoyant has completed 2 funding rounds, raising a total of $7.60M.
CellVoyant offers: FateView™ - AI-powered cell state prediction, FateDrive™ - AI-driven process optimisation.
Top alternatives and competitors to CellVoyant include Profluent, CellVoyant Technologies, Synthego, Perceiv, Unlearn.AI. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CellVoyant and Profluent are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CellVoyant, https://bouncewatch.com/company/cellvoyant, updated 26 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes